Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Larsen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Prosthetics and Orthotics International|July 20, 2021
A sensor to monitor limb depth in transtibial sockets with locking pin suspension: a technical noteSam Bennett, Clement Gurrey, Horace Wang, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2017
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort StudyCheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, et al.
Diabetes Care|July 24, 2013
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 peopleKamlesh Khunti, Michael L Wolden, Brian Larsen Thorsted, et al.
Journal of Managed Care & Specialty Pharmacy|February 7, 2018
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 DiabetesMichelle Mocarski, Jason Yeaw, Victoria Divino, et al.
Diabetes Care|December 11, 2014
Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort studyKamlesh Khunti, Melanie Davies, Azeem Majeed, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 14, 2017
POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRYAnne Peters, Michelle A Van Name, Brian Larsen Thorsted, et al.
Plos One|September 19, 2018
Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43)Jo Satoh, Marc Andersen, Brian Bekker Hansen, et al.
Diabetes, Obesity & Metabolism|February 12, 2019
Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidencePedro Mezquita Raya, Francisco Javier Ampudia Blasco, Barnaby Hunt, et al.
Journal of Medicinal Chemistry|August 23, 2012
Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performanceRuthann Nichols, Chloe Bass, Leslie Demers, et al.
Kidney International|September 30, 2011
Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritisSiranush A Sargsyan, Natalie J Serkova, Brandon Renner, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Prosthetics and Orthotics International|July 20, 2021
A sensor to monitor limb depth in transtibial sockets with locking pin suspension: a technical noteSam Bennett, Clement Gurrey, Horace Wang, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2017
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort StudyCheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, et al.
Diabetes Care|July 24, 2013
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 peopleKamlesh Khunti, Michael L Wolden, Brian Larsen Thorsted, et al.
Journal of Managed Care & Specialty Pharmacy|February 7, 2018
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 DiabetesMichelle Mocarski, Jason Yeaw, Victoria Divino, et al.
Diabetes Care|December 11, 2014
Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort studyKamlesh Khunti, Melanie Davies, Azeem Majeed, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 14, 2017
POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRYAnne Peters, Michelle A Van Name, Brian Larsen Thorsted, et al.
Plos One|September 19, 2018
Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43)Jo Satoh, Marc Andersen, Brian Bekker Hansen, et al.
Diabetes, Obesity & Metabolism|February 12, 2019
Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real-world clinical evidencePedro Mezquita Raya, Francisco Javier Ampudia Blasco, Barnaby Hunt, et al.
Journal of Medicinal Chemistry|August 23, 2012
Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performanceRuthann Nichols, Chloe Bass, Leslie Demers, et al.
Kidney International|September 30, 2011
Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritisSiranush A Sargsyan, Natalie J Serkova, Brandon Renner, et al.
Pageof 3